The efficiency of obesity treatment in patients with insomnia and obstructive sleep apnea syndrome
https://doi.org/10.14341/omet2016225-32
Abstract
The aim of this study was to investigate the relationship between the dynamics of body weight and sleep disorders in the treatment of obesity.
Materials and methods. The study included 200 obese patients: 83 men and 117 women.
Results. Complaints about problems sleeping (snoring, hypersomnia, insomnia, etc.) were present in 78% of obese patients. 89 patients were under the observation of an endocrinologist for 7 ± 1 months, they were divided into three matched by age, sex and BMI groups: patients with obstructive sleep apnea syndrome (OSAS) (n = 42), the second – with the syndrome of insomnia (n = 19), the third (control group) – patients without sleep disorders (n = 24). After treatment of obesity the weight loss in patients with insomnia syndrome was -2.5 [-4; 0]kg, in patients with OSAS -7 [-18; -2] kg, in patients without sleep disorders -6.5 [-12; -2.25] kg. Clinically significant weight reduction was reached in 25 (59.5%) patients with OSAS; 3 (16%) – with insomnia syndrome; 15 (62.5%) – without sleep disorders.
Conclusion. Thus, the insomnia syndrome essentially influences the obesity treatment results – most of patients with this sleep disorder (81.2%) do not achieve clinically significant weight loss. The presence and severity of breathing disorders during sleep do not prevent weight loss. However, with the regular use of CPAP-therapy in patients with OSAS has a tendency of greater reduction of body weight.
About the Authors
Natal'ya V. StruevaRussian Federation
MD, PhD
Competing Interests:
No conflict of interest
Galina A. Mel'nichenko
Russian Federation
MD, PhD, Professor
Competing Interests: No conflict of interest
Mikhail G. Poluektov
Russian Federation
MD, PhD
Competing Interests: No conflict of interest
Larisa V. Savel'eva
Russian Federation
MD, PhD
Competing Interests: No conflict of interest
References
1. Бузунов Р.В. Синдром обструктивного апноэ сна в сочетании с ожирением: особенности патогенеза, диагностики и лечения: Дисс. ... док. мед. наук. Москва; 2003. [Buzunov RV. Sindrom obstruktivnogo apnoe sna v sochetanii s ozhireniem: osobennosti patogeneza, diagnostiki i lecheniya. [dissertation] Moscow; 2003.(In Russ).] Доступно по: http://www.dissercat.com/content/sindrom-obstruktivnogo-apnoe-sna-v-sochetanii-s-ozhireniem-osobennosti-patogeneza-diagnostik Ссылка активна на 26.06.2016.
2. Гурова О.Ю. Метаболические и психические особенности пациентов с ожирением: Дис. ... канд. мед. наук. – Москва; 2010[Gurova OYu. Metabolicheskie i psikhicheskie osobennosti patsientov s ozhireniem. [dissertation] Moscow; 2010.(In Russ).] Доступно по: http://www.dissercat.com/content/metabolicheskie-i-psikhicheskie-osobennosti-patsientov-s-ozhireniem Ссылка активна на 26.06.2016.
3. Дедов И.И., Бутрова С.А., Савельева Л.В. Обучение больных ожирением (программа). Москва; 2001. [Dedov II, Butrova SA, Savel'eva LV. Obuchenie bol'nykh ozhireniem (programma). Moscow; 2001. (In Russ).]
4. Любшина О.В. Нарушения сна у больных с метаболическим синдромом и хроническими цереброваскулярными заболеваниями: Дис. ... док. мед. наук. – Москва; 2010 [Lyubshina OV. Narusheniya sna u bol'nykh s metabolicheskim sindromom i khronicheskimi tserebrovaskulyarnymi zabolevaniyam. [dissertation] Moscow; 2010.(In Russ).] Доступно по: http://www.dissercat.com/content/narushenie-sna-u-bolnykh-s-metabolicheskim-sindromom-i-khronicheskimi-tserebrovaskulyarnymi- Ссылка активна на
5. Полуэктов М.Г. Первичные и вторичные инсомнии и расстройства дыхания во сне //Журнал неврологии и психиатрии. – 2011. – Т. 9. – №. 2. – С. 10-18. [Poluektov MG. Pervichnye i vtorichnye insomnii i rasstroystva dykhaniya vo sne. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;9(2):10–18. (In Russ).]
6. Лечение морбидного ожирения у взрослых. Проект Национальных клинических рекомендаций // Ожирение и метаболизм. – 2010. – Т. 7. – №3 – C. 64-68. [Lechenie morbidnogo ozhireniya u vzroslykh. Proekt Natsional'nykh klinicheskikh rekomendatsiy.Obesity and metabolism. 2010;7(3):64-68. (In Russ).]doi: 10.14341/2071-8713-4996
7. Cappuccio FP, Taggart FM, Kandala N, et al. Meta-analysis of short sleep duration and obesity in children and adults. SLEEP. 2008;31(5):619.
8. Henley DE, Russell GM, Douthwaite JA, et al. Hypothalamic-Pituitary-Adrenal Axis Activation in Obstructive Sleep Apnea: The Effect of Continuous Positive Airway Pressure Therapy. The Journal of Clinical Endocrinology & Metabolism. 2009;94(11):4234-42. doi:10.1210/jc.2009-1174
9. International classification of sleep disorders, 2nd edn.: Diagnostic and coding manual. westchester, illinois: American academy of sleep medicine, 2005. broughton r. pathological fragmentary myoclonus, intensified sleep starts and hypnagogic foot tremor: three unusual sleep related disorders. Sleep. 2005;28:113-21.
10. Janson C, Lindberg E, Gislason T, et al. Insomnia in men-a 10-year prospective population based study. Sleep. 2001;24(4):425-30. PMID: 11403527.
11. Lanfranco F, Motta G, Minetto MA, Baldi M, Balbo M, Ghigo E, et al. Neuroendocrine Alterations in Obese Patients with Sleep Apnea Syndrome. International Journal of Endocrinology. 2010;2010:1-11. doi:10.1155/2010/474518
12. Ohayon MM, Reynolds CF. Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med. 2009;10(9):952-60. doi:10.1016/j.sleep.2009.07.008
13. Roth T, Coulouvrat C, Hajak G, et al. Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey. Biological Psychiatry. 2011;69(6):592-600. doi:10.1016/j.biopsych.2010.10.023
14. Sánchez-de-la-Torre M, Mediano O, Barceló A, et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep and Breathing. 2011;16(3):649-56. doi:10.1007/s11325-011-0552-7
15. Troxel WM; Buysse DJ; Matthews KA; Kip KE; Strollo PJ; Hall M; Drumheller O; Reis SE. Sleep symptoms predict the development of the metabolic syndrome. SLEEP 2010;33(12):1633-1640
16. Tuomilehto HPI, Seppä JM, Partinen MM, et al. Lifestyle Intervention with Weight Reduction. American Journal of Respiratory and Critical Care Medicine. 2009;179(4):320-7. doi:10.1164/rccm.200805-669OC
17. Vgontzas AN, Liao D, Pejovic S, et al. Insomnia With Objective Short Sleep Duration Is Associated With Type 2 Diabetes: A population-based study. Diabetes Care. 2009;32(11):1980-5. doi:10.2337/dc09-0284
18. Wolk R, Somers VK. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes, Obesity and Metabolism. 2006;8(3): 250-60. d
Supplementary files
![]() |
1. рис. 1 | |
Subject | ||
Type | Исследовательские инструменты | |
Download
(25KB)
|
Indexing metadata ▾ |
![]() |
2. рис. 2 | |
Subject | ||
Type | Исследовательские инструменты | |
Download
(57KB)
|
Indexing metadata ▾ |
![]() |
3. таблицы | |
Subject | ||
Type | Исследовательские инструменты | |
Download
(46KB)
|
Indexing metadata ▾ |
Review
For citations:
Strueva N.V., Mel'nichenko G.A., Poluektov M.G., Savel'eva L.V. The efficiency of obesity treatment in patients with insomnia and obstructive sleep apnea syndrome. Obesity and metabolism. 2016;13(2):25-32. (In Russ.) https://doi.org/10.14341/omet2016225-32

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).